Visugromab in Cachexia International Trial

A study of how well and safely a new drug called visugromab works in people with certain kinds of cancer (including lung and bowel cancer) and unintended weight loss known as cachexia. The main questi...

Lead sponsor: CatalYm GmbH•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Trial Director

CONTACT

49 8920006640 regulatory-006@catalym.com

Trial snapshot

StatusRECRUITING

PhasePHASE2/PHASE3

Enrollment518

Start dateApr 2026

Last updatedApr 23, 2026

Condition

Cancer-associated Cachexia

Locations shown

Mid Florida Hematology and Oncology Centers

Orange City, Florida

Specialized Hospital for Active Treatment in Oncology

Haskovo

Léon Bérard Center (Centre Léon Bérard)

Lyon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 23, 2026Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions